Literature DB >> 15640731

Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center.

Julia Haber1, Wilma Hopman, Manuel Gomez, Robert Cartotto.   

Abstract

Despite improved survival after burn center treatment for patients with toxic epidermal necrolysis (TEN), little is known about the overall long-term outcomes in these patients. In this work we sought to analyze late outcomes in survivors of TEN who were treated in our burn center. Subjects completed a questionnaire that included the RAND 36-Item Health Survey (SF-36) and the Dermatology Life Quality Index. Subjects were examined, when possible, and completed the Functional Independence Measure. Scores on the SF-36 were compared with age- and sex-matched National normative data. All results are presented as the mean +/- SD. Of 35 adults admitted with TEN between January 1, 1995, and January 6, 2003, 10 have died in hospital, 4 have died since discharge, and 8 have been lost to follow-up, leaving a study population of 13 subjects (age 45 +/- 18 years with initial %TBSA involvement 65 +/- 29). Follow-up occurred at 38 +/- 27 months after discharge. The most common ophthalmic problems were chronic photosensitivity (54%) and dry eyes (31%). The Dermatology Life Quality Index (maximum-worst score = 30) was 9 +/- 10. SF-36 scores were significantly lower than in the age- and sex-matched normal population across all domains except mental health. The Functional Independence Measure score (maximum-best score = 126) was 123 +/- 4. Survivors of TEN demonstrate a high level of independent function in activities of daily living, but numerous complications of TEN significantly impair their overall quality of life, emphasizing the need for long-term follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 15640731     DOI: 10.1097/01.bcr.0000150215.78220.79

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  15 in total

1.  [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].

Authors:  Argyrios Chronopoulos; Maja Mockenhaupt; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-03-16       Impact factor: 1.059

Review 2.  Severe cutaneous adverse drug reactions.

Authors:  Rajesh Verma; Biju Vasudevan; Vijendran Pragasam
Journal:  Med J Armed Forces India       Date:  2013-03-17

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2019-03-11       Impact factor: 5.033

5.  A case of toxic epidermal necrolysis (ten) with severe chronic ocular complications in a healthy 46-year-old woman.

Authors:  A Voltan; B Azzena
Journal:  Ann Burns Fire Disasters       Date:  2010-06-30

6.  Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.

Authors:  Jacqueline F Moreau; Robert S Watson; Mary E Hartman; Walter T Linde-Zwirble; Laura K Ferris
Journal:  Pediatr Dermatol       Date:  2013-05-16       Impact factor: 1.588

7.  Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; Leangelo Hall; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-03-19       Impact factor: 5.033

8.  Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom.

Authors:  Samir Jabbour; Nizar Din; Abison Logeswaran; Sara Taberno Sanchez; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2021-05-24

9.  The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.

Authors:  Leangelo N Hall; Swapna S Shanbhag; Ramy Rashad; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-05-20       Impact factor: 5.033

10.  USA: Ophthalmologic Evaluation and Management of Acute Stevens-Johnson Syndrome.

Authors:  Darren G Gregory
Journal:  Front Med (Lausanne)       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.